118 related articles for article (PubMed ID: 38599441)
1. Integration analysis of cell division cycle-associated family genes revealed potential mechanisms of gliomagenesis and constructed an artificial intelligence-driven prognostic signature.
Yu K; Tian Q; Feng S; Zhang Y; Cheng Z; Li M; Zhu H; He J; Li M; Xiong X
Cell Signal; 2024 Jul; 119():111168. PubMed ID: 38599441
[TBL] [Abstract][Full Text] [Related]
2. COL8A1 is a potential prognostic biomarker associated with migration, proliferation, and tumor microenvironment in glioma.
Liu M; Liang W; Su Y; Wen Y; Qi J; Wang L; Su S; Zhao J; Shan J; Wang J
Exp Cell Res; 2024 Jun; 439(1):114076. PubMed ID: 38719174
[TBL] [Abstract][Full Text] [Related]
3. Cuproptosis facilitates immune activation but promotes immune escape, and a machine learning-based cuproptosis-related signature is identified for predicting prognosis and immunotherapy response of gliomas.
Feng S; Zhang Y; Zhu H; Jian Z; Zeng Z; Ye Y; Li Y; Smerin D; Zhang X; Zou N; Gu L; Xiong X
CNS Neurosci Ther; 2024 Feb; 30(2):e14380. PubMed ID: 37515314
[TBL] [Abstract][Full Text] [Related]
4. Integrated bioinformatics analysis and experimental validation identified CDCA families as prognostic biomarkers and sensitive indicators for rapamycin treatment of glioma.
Li R; Chen Y; Yang B; Li Z; Wang S; He J; Zhou Z; Li X; Li J; Sun Y; Guo X; Wang X; Wu Y; Zhang W; Guo G
PLoS One; 2024; 19(1):e0295346. PubMed ID: 38181024
[TBL] [Abstract][Full Text] [Related]
5. A pan-cancer analysis reveals the diagnostic and prognostic role of CDCA2 in low-grade glioma.
Li W; Lv D; Yao J; Chen B; Liu H; Li W; Xu C; Li Z
PLoS One; 2023; 18(9):e0291024. PubMed ID: 37733705
[TBL] [Abstract][Full Text] [Related]
6. Lactate induced up-regulation of KLHDC8A (Kelch domain-containing 8A) contributes to the proliferation, migration and apoptosis of human glioma cells.
Zhu X; Chen T; Yang H; Lv K
J Cell Mol Med; 2020 Oct; 24(20):11691-11702. PubMed ID: 32851798
[TBL] [Abstract][Full Text] [Related]
7. Pard3 suppresses glioma invasion by regulating RhoA through atypical protein kinase C/NF-κB signaling.
Li J; Xu H; Wang Q; Fu P; Huang T; Anas O; Zhao H; Xiong N
Cancer Med; 2019 May; 8(5):2288-2302. PubMed ID: 30848088
[TBL] [Abstract][Full Text] [Related]
8. Bioinformatics analysis of the clinical relevance of CDCA gene family in prostate cancer.
Gu P; Yang D; Zhu J; Zhang M; He X
Medicine (Baltimore); 2022 Feb; 101(5):e28788. PubMed ID: 35119046
[TBL] [Abstract][Full Text] [Related]
9. Global analysis of iron metabolism-related genes identifies potential mechanisms of gliomagenesis and reveals novel targets.
Zhang J; Zhao L; Xuan S; Liu Z; Weng Z; Wang Y; Dai K; Gu A; Zhao P
CNS Neurosci Ther; 2024 Feb; 30(2):e14386. PubMed ID: 37545464
[TBL] [Abstract][Full Text] [Related]
10. Optimization of cancer immunotherapy through pyroptosis: A pyroptosis-related signature predicts survival benefit and potential synergy for immunotherapy in glioma.
Zeng Y; Cai Y; Chai P; Mao Y; Chen Y; Wang L; Zeng K; Zhan Z; Xie Y; Li C; Zhan H; Zhao L; Chen X; Zhu X; Liu Y; Chen M; Song Y; Zhou A
Front Immunol; 2022; 13():961933. PubMed ID: 35990696
[TBL] [Abstract][Full Text] [Related]
11. miR-139 Functions as An Antioncomir to Repress Glioma Progression Through Targeting IGF-1 R, AMY-1, and PGC-1β.
Wang H; Yan X; Ji LY; Ji XT; Wang P; Guo SW; Li SZ
Technol Cancer Res Treat; 2017 Aug; 16(4):497-511. PubMed ID: 26868851
[TBL] [Abstract][Full Text] [Related]
12. Orphan nuclear receptor TLX promotes immunosuppression via its transcriptional activation of PD-L1 in glioma.
Zhou J; Pei X; Yang Y; Wang Z; Gao W; Ye R; Zhang X; Liu J; Liu Z; Yang X; Tao J; Gu C; Hu W; Chan FL; Li X; Mao J; Wu D
J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33858847
[TBL] [Abstract][Full Text] [Related]
13. TAGLN2 is a candidate prognostic biomarker promoting tumorigenesis in human gliomas.
Han MZ; Xu R; Xu YY; Zhang X; Ni SL; Huang B; Chen AJ; Wei YZ; Wang S; Li WJ; Zhang Q; Li G; Li XG; Wang J
J Exp Clin Cancer Res; 2017 Nov; 36(1):155. PubMed ID: 29110682
[TBL] [Abstract][Full Text] [Related]
14. Loss of 5'-Methylthioadenosine Phosphorylase (MTAP) is Frequent in High-Grade Gliomas; Nevertheless, it is Not Associated with Higher Tumor Aggressiveness.
Menezes WP; Silva VAO; Gomes INF; Rosa MN; Spina MLC; Carloni AC; Alves ALV; Melendez M; Almeida GC; Silva LSD; Clara C; da Cunha IW; Hajj GNM; Jones C; Bidinotto LT; Reis RM
Cells; 2020 Feb; 9(2):. PubMed ID: 32093414
[TBL] [Abstract][Full Text] [Related]
15. miR-320a functions as a suppressor for gliomas by targeting SND1 and β-catenin, and predicts the prognosis of patients.
Li H; Yu L; Liu J; Bian X; Shi C; Sun C; Zhou X; Wen Y; Hua D; Zhao S; Ren L; An T; Luo W; Wang Q; Yu S
Oncotarget; 2017 Mar; 8(12):19723-19737. PubMed ID: 28160566
[TBL] [Abstract][Full Text] [Related]
16. TUBA1C expression promotes proliferation by regulating the cell cycle and indicates poor prognosis in glioma.
Gui S; Chen P; Liu Y; Chen Q; Cheng T; Lv S; Zhou T; Song Z; Xiao J; He W; Yuan S; Cheng Z
Biochem Biophys Res Commun; 2021 Nov; 577():130-138. PubMed ID: 34517210
[TBL] [Abstract][Full Text] [Related]
17. Glioma stem cell signature predicts the prognosis and the response to tumor treating fields treatment.
Chen B; Zhou X; Yang L; Zhou H; Meng M; Wu H; Liu Z; Zhang L; Li C
CNS Neurosci Ther; 2022 Dec; 28(12):2148-2162. PubMed ID: 36070228
[TBL] [Abstract][Full Text] [Related]
18. Identification of PIEZO1 as a potential prognostic marker in gliomas.
Zhou W; Liu X; van Wijnbergen JWM; Yuan L; Liu Y; Zhang C; Jia W
Sci Rep; 2020 Sep; 10(1):16121. PubMed ID: 32999349
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Gene Expression Signature in Patients With Distinct Glioma Grades.
Ait Ssi S; Chraa D; El Azhary K; Sahraoui S; Olive D; Badou A
Front Immunol; 2021; 12():685213. PubMed ID: 34539626
[TBL] [Abstract][Full Text] [Related]
20. HIF-1α-mediated LAMC1 overexpression is an unfavorable predictor of prognosis for glioma patients: evidence from pan-cancer analysis and validation experiments.
Bai J; Zhao Y; Shi K; Fan Y; Ha Y; Chen Y; Luo B; Lu Y; Jie W; Shen Z
J Transl Med; 2024 Apr; 22(1):391. PubMed ID: 38678297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
